[HTML][HTML] Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors

M Lange, F Joly, J Vardy, T Ahles, M Dubois, L Tron… - Annals of …, 2019‏ - Elsevier
Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

Sex and gender differences in Alzheimer's disease dementia

MM Mielke - The Psychiatric times, 2018‏ - pmc.ncbi.nlm.nih.gov
Alzheimer's disease (AD) dementia is the most common form of dementia, comprising 60 to
70 percent of all cases. AD is a progressive neurodegenerative disease that causes memory …

The increasing value of eHealth in the delivery of patient-centred cancer care

FJ Penedo, LB Oswald, JP Kronenfeld… - The Lancet …, 2020‏ - thelancet.com
The increasing use of eHealth has ushered in a new era of patient-centred cancer care that
moves beyond the traditional in-person care model to real-time, dynamic, and technology …

Long-term cognitive dysfunction in cancer survivors

Z Országhová, M Mego, M Chovanec - Frontiers in molecular …, 2021‏ - frontiersin.org
Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …

Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective

MM Mielke, NT Aggarwal, C Vila‐Castelar… - Alzheimer's & …, 2022‏ - Wiley Online Library
Sex or gender differences in the risk of Alzheimer's disease and related dementias (ADRD)
differ by world region, suggesting that there are potentially modifiable risk factors for …

Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?

SB Schagen, AS Tsvetkov, A Compter… - Nature Reviews …, 2022‏ - nature.com
One in three people will be diagnosed with cancer during their lifetime. The community of
cancer patients is growing, and several common cancers are becoming increasingly …

Association between androgen deprivation therapy and risk of dementia

KT Nead, G Gaskin, C Chester… - JAMA …, 2017‏ - jamanetwork.com
Importance A growing body of evidence supports a link between androgen deprivation
therapy (ADT) and cognitive dysfunction, including Alzheimer disease. However, it is …

Management of prostate cancer in older adults

LS Graham, JK Lin, DE Lage, ER Kessler… - American Society of …, 2023‏ - ascopubs.org
The majority of men with prostate cancer are diagnosed when they are older than 65 years;
however, clinical trial participants are disproportionately younger and more fit than the real …

Association of second-generation antiandrogens with cognitive and functional toxic effects in randomized clinical trials: a systematic review and meta-analysis

MK Nowakowska, RM Ortega, MR Wehner… - JAMA …, 2023‏ - jamanetwork.com
Importance The use of second-generation antiandrogens (AAs) in the treatment of prostate
cancer is increasing. Retrospective evidence suggests an association between second …

Impact of testosterone on Alzheimer's disease

VE Bianchi - The World Journal of Men's Health, 2022‏ - pmc.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a neurodegenerative disease responsible for almost half of all
dementia cases in the world and progressively increasing. The etiopathology includes …